SRX Global Reports Preliminary Net Asset Value of Approximately $3.07 Per Share and Over $55 Million in Cash and Short-Term Investments(1)

SRX Global says it ended its EMJX acquisition with no debt outstanding and an estimated NAV of ~$60M (about $3.07 per share), supported by ~$40M cash and $15M+ in short-term investments as of June 30, 2026. The company reports ~19.52M shares outstanding after a 1-for-60 reverse split effective July 6, 2026, and management does not anticipate additional capital raises. Overall, the balance sheet de-leveraging and liquidity increase provide added flexibility for treasury optimization and value-accretive strategic investments.

Analysis

The near-term read is not “story stock strength,” it is a balance-sheet de-risking event that can temporarily re-rate a thinly traded equity if investors believe the cash is real and sticky. Post-split optics can amplify price moves, but they also make the name more vulnerable to liquidity vacuum once the initial headline bid fades; the float reduction is a double-edged sword for both squeezes and sharp air pockets.

The key mechanism over the next 1-3 months is NAV credibility versus holdco discount. If the upcoming filing confirms the cash build and there is no surprise from acquisition accounting, the stock can trade closer to a sum-of-the-parts floor; if not, the market will quickly impose a larger discount for overhead, valuation uncertainty, and the risk that “treasury optimization” becomes a euphemism for lower-quality risk taking. Any incremental deployment into non-core assets with weak mark transparency should be viewed as a negative, not a growth catalyst.

Over 6-18 months, this is less about capital structure and more about proof of compounding. Without visible operating ROIC at Halo or realized gains from disciplined investments, the equity is likely to behave like a public net-asset vehicle with an active-management tax embedded in the stock price. The consensus may be overpricing the optionality language around AI-enabled investing; the more important question is whether management can earn above cost of capital without reintroducing dilution or illiquid asset risk.

Key Decisions for Investors

• No immediate chase: wait for the 10-Q on/around Aug. 14 to verify cash, short-term investments, and any acquisition-related adjustments before underwriting the $3.07/share NAV claim.
• If SRXH gaps up materially on the headline, consider fading the move with a small short or put spread into the filing; target a reversion toward a 25-40% holdco discount if liquidity normalizes, with a tight stop if the filing confirms asset quality cleanly.
• If the filing confirms NAV and no hidden dilution, consider a tactical long on pullbacks only; risk/reward is roughly 15-25% upside to a narrower discount versus low-single-digit downside if cash burns or marks disappoint.
• Set a hard alert for any increase in share count, debt, or a meaningful drop in cash after the next filing; that would falsify the “self-funded capital allocator” thesis and likely remove the bid entirely.